Growth Metrics

Sarepta Therapeutics (SRPT) Amortizatization of Intangibles (2016 - 2025)

Sarepta Therapeutics has reported Amortizatization of Intangibles over the past 9 years, most recently at -$380000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 94.41% year-over-year to -$380000.0; the TTM value through Dec 2025 reached -$5.3 million, up 86.86%, while the annual FY2025 figure was -$5.3 million, 86.86% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$380000.0 at Sarepta Therapeutics, up from -$1.1 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at -$50000.0 in Q1 2022 and troughed at -$13.3 million in Q4 2023.
  • A 4-year average of -$6.4 million and a median of -$6.5 million in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: plummeted 17202.0% in 2023 and later skyrocketed 94.41% in 2025.
  • Year by year, Amortizatization of Intangibles stood at -$6.1 million in 2022, then crashed by 117.33% to -$13.3 million in 2023, then soared by 48.96% to -$6.8 million in 2024, then skyrocketed by 94.41% to -$380000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for SRPT at -$380000.0 in Q4 2025, -$1.1 million in Q3 2025, and -$1.9 million in Q2 2025.